MicroSintesis Inc.: federal grants and contributions: 16 agreements; $2.1M value; 3 departments; 5 programs.
Assay record ASY-CA-15F8KBO06E · Cite as: Assay Systems, “MicroSintesis Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/microsintesis-inc/
MicroSintesis is developing novel microbiome solutions to target human and animal disease. We will investigate the use and application of natural probiotic metabolites to modulate the microbiome to improve health and wellness.
Support the launch of proteobiotics for animal health in Canada, United States and Europe
Acquire equipment to scale-up production capacity and improve productivity
MicroSintesis is developing a Bioassay Platform that will be used to determine the potency of current and future products, and to validate the anti-virulence mode of action of candidate products against target pathogens of commercial interest. The collection of analytical and biological assays for the Bioassay Platform will monitor: 1) Virulence and Quorum Sensing Gene Expression changes, in selected pathogens, to the presence of the technology 2) Phenotypic behavioural response of selected pathogen to virulence gene changes 3) In vivo Clinical response to pathogen behaviour changes due to q
Hire a senior project manager
Hire a clinical program coordinator
MicroSintesis is a new biotechnology company specializing in the science of proteobiotics, bio-active metabolites produced by probiotics. Using proprietary fermentation and strain selection techniques, we are creating a new generation of scientifically advanced probiotics._x000D_ _x000D_ With this project, MicroSintesis will expand the commercial application for our technology and evaluate the efficacy of proteobiotics to impact the ability of the anaerobic pathogen, Clostridium perfringens, to cause infection in poultry. To do this, we will develop the anaerobic assays and production methods
MicroSintesis is a new biotechnology company specializing in the science of proteobiotics; bio-active metabolites produced by probiotics. Using proprietary fermentation and strain selection techniques we are creating a new generation of scientifically advanced probiotics.
MicroSintesis will be testing the efficacy of proteobiotics and their ability to reduce Necrotic Enteritis in poultry. A proteobiotic dose response will be compared to a commercial antibiotic used to treat Necrotic Enteritis.
Establish laboratory facilities
Through the application of national and local priorities, the CSJ program seeks to provide youth who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills. The CSJ program is delivered by the Department of ESD.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.